D.A. Davidson & Co. Anixa Biosciences Inc Transaction History
D.A. Davidson & Co.
- $13.8 Billion
- Q2 2025
A detailed history of D.A. Davidson & Co. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 614,272 shares of ANIX stock, worth $2.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
614,272
Previous 614,272
-0.0%
Holding current value
$2.71 Million
Previous $1.76 Million
15.43%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.33MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$6.14 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.72 Million0.28% of portfolio
-
Ubs Group Ag505KShares$2.23 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.63 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA343KShares$1.51 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $135M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...